CSL Vifor is a global specialty pharmaceuticals company in the treatment areas of iron deficiency, dialysis, nephrology & rare disease. It is headquartered in Switzerland and consists of CSL Vifor, Vifor Fresenius Medical Care Renal Pharma and Sanifit Therapeutics. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Vifor Pharma (Switzerland), Switzerland, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
57%
Total
Publications
1.1K
Total Open
Publications
634
Total
Citations
32K
Open Access
Percentage
57%
Total
Publications
1.1K
Total Open
Publications
634
Total
Citations
32K
Breakdown
Publisher Open
24%
Both
25%
Other Platform Open
8%
Closed
43%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 28%
156
Hybrid 46%
250
No Guarantees 26%
143
Other Platform Open
Domain 68%
250
Institution 41%
149
Other Internet 23%
85
Public 8%
31
Preprint 8%
28
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 249 |
Europe PMC | Domain | 101 |
Paul Scherrer Institute - DORA PSI | Other Internet | 46 |
University of Groningen / Centre for Information Technology - University of Groningen research database | Institution | 35 |
Semantic Scholar | Public | 30 |
University College London - UCL Discovery | Institution | 26 |
St George's University of London - St George's Online Research Archive | Institution | 22 |
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System | Institution | 21 |
arXiv | Preprint | 19 |
University of Zurich - Zurich Open Repository and Archive | Institution | 18 |